ID: ALA3403527

Max Phase: Preclinical

Molecular Formula: C14H16N4O2S

Molecular Weight: 304.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(S(=O)(=O)Nc2ccc(NC(=N)N)cc2)cc1

Standard InChI:  InChI=1S/C14H16N4O2S/c1-10-2-8-13(9-3-10)21(19,20)18-12-6-4-11(5-7-12)17-14(15)16/h2-9,18H,1H3,(H4,15,16,17)

Standard InChI Key:  YEBKIPDWIJVJKE-UHFFFAOYSA-N

Associated Targets(Human)

Hepatocyte growth factor activator 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.38Molecular Weight (Monoisotopic): 304.0994AlogP: 2.10#Rotatable Bonds: 4
Polar Surface Area: 108.07Molecular Species: BASEHBA: 3HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.38CX Basic pKa: 8.78CX LogP: 1.46CX LogD: 0.82
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.51Np Likeness Score: -1.33

References

1. Franco FM, Jones DE, Harris PK, Han Z, Wildman SA, Jarvis CM, Janetka JW..  (2015)  Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.,  23  (10): [PMID:25882520] [10.1016/j.bmc.2015.03.072]

Source